➲ Home ➲ C-19 Archives
‘We are entering a phase of long COVID and chronic disability.’
❂
❦ ‘As the numbers of hospitalizations and deaths are dropping, many individuals declare the pandemic all but over, comforted by the belief that infections are mild and less dangerous than the seasonal flu.
However, the scientific literature these last few weeks has been filled with deeply concerning reports.
We are entering a phase of long COVID and chronic disability.
The number of COVID-19 cases in the United States is unknown since our case reporting system has become unreliable and substantially undercounts cases.
In England, as of the week ending March 7, 2023, 1 in 40 people is positive for COVID-19, and reinfections are frequently occurring.
It is estimated that as of November 9, 2022, 94% of the U.S. population has been infected by SARS-CoV-2, and 65% of the United States population has been infected multiple times.
The odds of self-reported long COVID were 28% less after the second infection. Unfortunately, the
damage of long COVID from a
second infection adds to the first.
One of the most concerning
long-term effects of COVID-19 is
immune dysfunction or
hypofunction.
Confirmatory research was reported this week, and summarized in a National Institute of Health news release which stated:
‘… findings suggest that SARS-CoV-2 infection damages the CD8⁺ T cell response, an effect akin to that observed in earlier studies showing long-term damage to the immune system after infection with viruses such as hepatitis C or HIV.’
The authors conclude that this dysfunction causes lasting damage and may ‘contribute to long COVID, perhaps rendering patients unable to respond robustly to subsequent infections by SARS-CoV-2 variants or other pathogens.’ *
* 📖 (20 Mar 2023 ~ National Institutes for Health) SARS-CoV-2 infection weakens immune-cell response to vaccination ➤
These findings mirror those reported by Files et al who state:
‘Overall, expression of these activation and exhaustion markers indicated more severe immune dysregulation of CD8⁺ T cells in the hospitalized group.’
And they found that ‘CD8⁺ T cell expression of exhaustion markers increased in non-hospitalized individuals over time’. *
*
📖
(4 Jan 2021 ~ Journal of Clinical Investigation)
Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection ➤
The authors’ finding of damage to the immune system “akin” to HIV is very concerning, as is the amplification of this result in the NIH news release.
Infection Control Today previously reported that the probable cause of the surges in infections we are seeing is an immune dysfunction caused by COVID-19.
With minimal public health interventions, Sweden also experienced surges in respiratory syncytial virus (RSV) cases.
Most recently, Sweden has undergone a significant surge in seasonal flu, with reports from the Public Health Agency of Sweden of unusually severe cases.
These [Swedish influenza] cases have occurred in ‘... people under the age of 18 without underlying disease or condition, and have been very seriously ill with complications such as myocarditis or encephalitis.’ Other diseases are also rising, exemplified by reports of record-high severe Streptococcal infections and Candida auris.
These
spikes
in
infections
caused by multiple pathogens are associated with the SARS-CoV-2 pandemic and the mounting evidence of post-COVID-19 immune dysfunction.
Vaccinations can not only reduce the incidence of severe disease, but can also help to prevent long COVID, reducing the incidence by 30% to 40%.
However, we have expressed concern regarding the bivalent booster’s effectiveness, and reported a rapid waning of booster-induced immunity in the elderly. [See Footnote.]
Recently, researchers from the United States found that the relative bivalent booster effectiveness at 5 to 7 months in preventing hospitalizations relative to monovalent vaccine dosages (2, 3, or 4) was 42% and 59% compared to no vaccination.
Using the third vaccine dose as a baseline, the UK Health Security Agency found that an additional (fourth) vaccine dosage had effectiveness against hospitalizations at 10 weeks of only 50%.’
Source: 📖 (21 Mar 2023 ~ Infection Control Today) COVID-19: Study Suggests Long-term Damage to Immune System ➤
❂
Footnote: On waning vaccine effectiveness
* ‘Vaccine effectiveness is an important point. Although much of the younger population received a get-out-of-hospital free card for the latest variant, senior citizens were in its crosshairs.
During the last 6 months (since May of 2022), those over the age of 75 had a higher rate of hospitalizations than in the Delta surge; those between the ages of 65 and 75 had approximately the same.
Both age groups continue to be at high risk for death and disability.
However, data showed that for those 65 years of age and older, the monovalent vaccine’s (2 or more doses) effectiveness for preventing hospitalizations fell to 28% in less than a year.
Results were worse for those individuals under 65 years – only 19%.’
* 📖 (24 Feb 2023 ~ Infection Control Today) How Soon Is Another Booster Needed? Durability of Vaccine-Induced Immunity ➤
❂
© 2023
Infection Control Today.
➲
Learn more ➲ Immunity
Useful search tags:
air filtration / babies & children / body / brain / C19.Life / cancer / comment / dementia / economy / elders / excess deaths / exercise / flu / heart / history / immunity / influenza / law / long covid / NHS / PEM / propaganda / reinfections / reproduction and pregnancy / resources / respirators / respiratory / schools / solutions / transmission / UVC / vaccines / variants / WHO / zoonosis
You are free to disagree with anything you read here, provided that you have an authentic, evidence-based argument for it.
❦ All content on this website is for informational and educational purposes only.
c19.life